Under the proposal, only those who are considered obese — someone who has a body mass index of 30 or higher — would qualify ...
Shares of weight-loss drugmakers Novo Nordisk and Eli Lilly rose on Tuesday after U.S. President Joe Biden proposed expanding ...
CMS proposes changes to Medicare and Medicaid to cover weight-loss drugs, recognizing obesity as a disease. This could expand ...
The Biden administration’s latest proposal to allow Medicare and Medicaid to cover weight loss drugs such as Ozempic and ...
The plans from the Department of Health and Human Services come on the heels of criticism Ozempic and other weight loss medications received by RFK Jr.
Biden administration's proposal to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid.
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...
The White House said Tuesday it is moving to make Medicare and Medicaid cover anti-obesity drugs such as Novo Nordisk’s ...
The Biden administration on Tuesday proposed expanding drug coverage under Medicare and Medicaid to include anti-obesity ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
The Biden administration on Tuesday proposed that weight-loss drugs be paid for by Medicaid and Medicare, potentially making ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.